Showing 1 - 20 results of 1,173 for search '(( status ((((we decrease) OR (mean decrease))) OR (small decrease)) ) OR ( a largest decrease ))', query time: 0.51s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

    Published 2025
    “…The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
  14. 14
  15. 15

    Characteristics of the population studied. by Diego Rafael Batista (19746556)

    Published 2024
    “…One of the negative perceptions identified in the study involves a misunderstanding of the association between PrEP users and the HIV/AIDS status. …”
  16. 16

    Overview of the validated interview guide. by Diego Rafael Batista (19746556)

    Published 2024
    “…One of the negative perceptions identified in the study involves a misunderstanding of the association between PrEP users and the HIV/AIDS status. …”
  17. 17
  18. 18
  19. 19
  20. 20